Literature DB >> 6378917

Alcoholdehydrogenase as an activating enzyme for N-nitrosodiethanolamine (NDELA): in vitro activation of NDELA to a potent mutagen in Salmonella typhimurium.

G Eisenbrand, E Denkel, B Pool.   

Abstract

N-Nitrosodiethanolamine (NDELA), a potent carcinogen, has not so far been found to be mutagenic in a wide range of test systems. In particular, mutagenicity testing in Salmonella typhimurium with rat liver S-9 mix or microsomal fraction used for activation has failed to indicate mutagenicity. However, when incubated with alcohol dehydrogenase (ADH) in the presence of NAD, NDELA is converted to a potent mutagen. A possible mechanism of activation comprises the generation of an aldehyde as a primary metabolite formed by NAD/ADH and its subsequent rearrangement into cyclic intermediates. The latter might either be further metabolized or spontaneously decompose into various alkylating agents and glycolaldehyde. Standard test conditions used for the Ames test will not favor the detection of mutagens to be activated by NAD/ADH because they require the presence of NADPH, whereas ADH needs NAD to become an activating enzyme, as shown for NDELA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378917     DOI: 10.1007/bf00390977

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  23 in total

1.  Mutagenicity of N-nitrosodiethanolamine and its acetyl-derivatives [proceedings].

Authors:  P Gilbert; B Rollmann; J Rondelet; M Mercier; F Poncelet
Journal:  Arch Int Physiol Biochim       Date:  1979-10

2.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

3.  Urinary excretion of N-nitrosodiethanolamine in rats following its epicutaneous and intratracheal administration and its formation in vivo following skin application of diethanolamine.

Authors:  R Preussmann; B Spiegelhalder; G Eisenbrand; G Würtele; I Hofmann
Journal:  Cancer Lett       Date:  1981-08       Impact factor: 8.679

4.  N-Nitrosodiethanolamine in cosmetics, lotions and shampoos.

Authors:  T Y Fan; U Goff; L Song; D H Fine; G P Arsenault; K Biemann
Journal:  Food Cosmet Toxicol       Date:  1977-10

5.  Mutagenicity of nitrosodiethanolamine on Salmonella typhimurium.

Authors:  A Hesbert; M Lemonnier; C Cavelier
Journal:  Mutat Res       Date:  1979-11       Impact factor: 2.433

6.  The mutagenicity of 45 nitrosamines in the Salmonella typhimurium.

Authors:  A W Andrews; W Lijinsky
Journal:  Teratog Carcinog Mutagen       Date:  1980

7.  Potent carcinogenicity of nitrosodiethanolamine in rats.

Authors:  W Lijinsky; M D Reuber; W B Manning
Journal:  Nature       Date:  1980-12-11       Impact factor: 49.962

8.  Urinary excretion of N-nitrosamines in rats and humans.

Authors:  B Spiegelhalder; G Eisenbrand; R Preussmann
Journal:  IARC Sci Publ       Date:  1982

9.  N-Nitrosodiethanolamine in synthetic cutting fluids: a part-per-hundred impurity.

Authors:  T Y Fan; J Morrison; D P Rounbehler; R Ross; D H Fine; W Miles; N P Sen
Journal:  Science       Date:  1977-04-01       Impact factor: 47.728

10.  The superiority of hamster liver microsomal fraction for activating nitrosamines to mutagens in Salmonella typhimurium.

Authors:  W Lijinsky; A W Andrews
Journal:  Mutat Res       Date:  1983-10       Impact factor: 2.433

View more
  10 in total

1.  Biological activity of N-nitrosodiethanolamine and of potential metabolites which may arise after activation by alcohol dehydrogenase in Salmonella typhimurium, in mammalian cells, and in vivo.

Authors:  E Denkel; B L Pool; J R Schlehofer; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Increased mutagenicity of N-nitrosodiethanolamine in human lymphocyte cultures after activation by alcohol dehydrogenase.

Authors:  I Henn; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 3.  Metabolic Activation and DNA Interactions of Carcinogenic N-Nitrosamines to Which Humans Are Commonly Exposed.

Authors:  Yupeng Li; Stephen S Hecht
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 4.  DNA adducts and DNA damage by antineoplastic and carcinogenic N-nitrosocompounds.

Authors:  G Eisenbrand; N Müller; E Denkel; W Sterzel
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

5.  Studies on the metabolic activation of diethanolnitrosamine in animal-mediated and in vitro assays using Escherichia coli K-12 343/113 as an indicator.

Authors:  S Knasmüller; G Stehlik; G Mohn
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  The effect of mixed-function oxidase and amine oxidase inhibitors on the activation of dialkylnitrosamines and 1,2-dimethylhydrazine to bacterial mutagens in mice.

Authors:  P R Kerklaan; S Bouter; J A Zijlstra; G R Mohn
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

7.  N-nitrosodiethanolamine is activated in the rat to an ultimate genotoxic metabolite by sulfotransferase.

Authors:  W Sterzel; G Eisenbrand
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

8.  Cytogenetic effects of N-nitrosodiethanolamine (NDELA) and NDELA-monoacetate in human lymphocytes.

Authors:  U Dittberner; G Eisenbrand; H Zankl
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  Biological monitoring of workers exposed to N-nitrosodiethanolamine in the metal industry.

Authors:  S Monarca; G Scassellati-Sforzolini; F Donato; G Angeli; B Spiegelhalder; C Fatigoni; R Pasquini
Journal:  Environ Health Perspect       Date:  1996-01       Impact factor: 9.031

10.  Monitoring nitrite, N-nitrosodiethanolamine, and mutagenicity in cutting fluids used in the metal industry.

Authors:  S Monarca; G Scassellati Sforzolini; B Spiegelhalder; R Pasquini; C Fatigoni
Journal:  Environ Health Perspect       Date:  1993-06       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.